Dry Needling and Rehabilitatin Carpal Tunnel Syndrome

NCT ID: NCT06358326

Last Updated: 2025-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

78 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-05

Study Completion Date

2024-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dry needling is used for myofascial release. However, its effectiveness in carpal tunnel syndrome (CTS) is not well known. It is thought that dry needling may also be an effective treatment for CTS by providing relaxation in the fascial tissue. Therefore, this study will examine the effects of dry needling treatment on pain, function, range of motion, proprioception and disability in patients with CTS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy in the society, which develops due to compression of the median nerve in the carpal tunnel. With the compression of the median nerve, a pain, numbness and tingling sensation spreading to the hand and wrist affects daily living activities and reduces the quality of life. Thickening and myofascial restriction in the carpal tunnel area also contribute to this situation. For this reason, various treatment methods have been developed for CTS, ranging from conservative treatment to surgery. Dry needling is also an alternative treatment method that can be used for CTS. Dry needling allows the fascial tissue to loosen and re-enter the healing process, leading to a decrease in pain and an increase in quality of life. However, its effectiveness in patients with CTS is unknown. This study aimed to examine the effectiveness of dry needling in patients with CTS.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Needling Carpal Tunnel Syndrome Myofacial Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Parallel Assignment
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors
Triple-blind study; the patients will not be informed about their groups (training group or the control group) and they will be evaluated and trained at different places and times.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment Group

In addition to the exercise given to the control group, the treatment group will receive dry needling in the carpal tunnel area, 2 days a week for 3 weeks, for a total of 5 sessions.

Group Type EXPERIMENTAL

Dry needling

Intervention Type OTHER

In addition to stretching, nerve mobilization and tendon gliding exercises, a total of 5 sessions of dry needling will be performed for fascial mobilization, 2 days a week for 3 weeks.

Control Group

The control group will be taught and asked to perform stretching, nerve mobilization and tendon-shifting exercises for 3 weeks.

Group Type ACTIVE_COMPARATOR

Control group

Intervention Type OTHER

The physiotherapist will teach stretching, neuromobilization and tendon shifting exercises and will be asked to do them regularly for 3 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dry needling

In addition to stretching, nerve mobilization and tendon gliding exercises, a total of 5 sessions of dry needling will be performed for fascial mobilization, 2 days a week for 3 weeks.

Intervention Type OTHER

Control group

The physiotherapist will teach stretching, neuromobilization and tendon shifting exercises and will be asked to do them regularly for 3 weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Volunteering to participate in the study.
2. Being between the ages of 18-65.
3. Being diagnosed with mild or moderate stage CTS as a result of the electroneurophysiological test.

Exclusion Criteria

1. Having additional neurological, rheumatological and orthopedic disorders.
2. Having had previous hand surgery.
3. Having an additional acute neck, shoulder, elbow and hand problem.
4. Having a BMI of 40 kg/m2 and above.
5. Being pregnant.
6. As a result of the electroneurophysiological test, the data related to the median nerve are at a severe level.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Karabuk University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Musa Güneş

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fidan Yılmaz, MsC

Role: PRINCIPAL_INVESTIGATOR

Pursaklar State Hospital

Emime EMİRMAHMUTOĞLU, Bachelors

Role: PRINCIPAL_INVESTIGATOR

Pursaklar State Hospital

Banu Gökçen BAYDOĞAN TAN, MD

Role: STUDY_DIRECTOR

Pursaklar State Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pursaklar State Hospital

Ankara, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Karabuk-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.